Company / EPS (Diluted)
Biohaven Ltd. EPS (Diluted) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$9.28
FY2024
5-year range
-$12.75 / -$3.01
FY2020-FY2024
Trend
-62.0%
vs FY2023
Sector context
#197 of 204
Health Care
What the data says
Among 204 Health Care companies, Biohaven Ltd. is in the bottom 3% for eps (diluted). Improved from $-12.75 to $-9.28 over the past 2 years.
Based on SEC 10-K filings.
-9.28 in FY2024.
Improved from $-12.75 to $-9.28 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 204This company -$9.28 Sector average -$0.98
▼
-847.3% below sector average
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 62.0% year-over-year.
- Ranks #197 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$9.28 | -62.0% |
| FY2023 | -$5.73 | +55.1% |
| FY2022 | -$12.75 | -134.8% |
| FY2021 | -$5.43 | -80.4% |
| FY2020 | -$3.01 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026